# Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition

> **NCT02579460** · NA · COMPLETED · sponsor: **Dallas VA Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Barrett's Esophagus
- Gastroesophageal Reflux Disease

## Interventions

- **OTHER:** Cessation of Acid Suppressing Medications

## Key facts

- **NCT ID:** NCT02579460
- **Lead sponsor:** Dallas VA Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02579460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02579460, "Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02579460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*